A detailed history of Macquarie Group LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 4,487,785 shares of MRK stock, worth $510 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
4,487,785
Previous 4,955,422 9.44%
Holding current value
$510 Million
Previous $654 Million 15.03%
% of portfolio
0.65%
Previous 0.75%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$123.8 - $132.96 $57.9 Million - $62.2 Million
-467,637 Reduced 9.44%
4,487,785 $556 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $115 Million - $134 Million
-1,015,610 Reduced 17.01%
4,955,422 $654 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $41.4 Million - $45.1 Million
-413,549 Reduced 6.48%
5,971,032 $651 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $46.1 Million - $51.2 Million
-448,024 Reduced 6.56%
6,384,581 $657 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $68 Million - $74.1 Million
-626,292 Reduced 8.4%
6,832,605 $788 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $2.07 Million - $2.31 Million
20,081 Added 0.27%
7,458,897 $794 Million
Q4 2022

Feb 21, 2023

SELL
$87.44 - $112.11 $116 Million - $149 Million
-1,326,950 Reduced 15.14%
7,438,816 $825 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $42.4 Million - $47.6 Million
-501,216 Reduced 5.41%
8,765,766 $755 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $113 Million - $128 Million
-1,357,173 Reduced 12.77%
9,266,982 $845 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $28.8 Million - $32.2 Million
-391,287 Reduced 3.55%
10,624,155 $871 Million
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $66.2 Million - $82.9 Million
-915,657 Reduced 7.67%
11,015,442 $844 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $12.5 Million - $13.8 Million
174,848 Added 1.49%
11,931,099 $896 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $68.5 Million - $75.8 Million
974,638 Added 9.04%
11,756,251 $914 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $5 Million - $5.89 Million
-72,570 Reduced 0.67%
10,781,613 $831 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $19.7 Million - $21.9 Million
-274,502 Reduced 2.47%
10,854,183 $888 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $33.5 Million - $37.9 Million
-457,241 Reduced 3.95%
11,128,685 $923 Million
Q2 2020

Aug 11, 2020

SELL
$70.42 - $80.13 $18.1 Million - $20.5 Million
-256,331 Reduced 2.16%
11,585,926 $896 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $88.7 Million - $123 Million
-1,400,540 Reduced 10.58%
11,842,257 $911 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $105 Million - $119 Million
1,353,763 Added 11.39%
13,242,797 $1.2 Billion
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $10.3 Million - $11.2 Million
-135,622 Reduced 1.13%
11,889,034 $1 Billion
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $22 Million - $25.7 Million
-314,615 Reduced 2.55%
12,024,656 $1.01 Billion
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $39.1 Million - $44.6 Million
-562,011 Reduced 4.36%
12,339,271 $1.03 Billion
Q4 2018

Feb 15, 2019

SELL
$65.24 - $75.71 $61.6 Million - $71.5 Million
-943,813 Reduced 6.82%
12,901,282 $986 Million
Q3 2018

Nov 15, 2018

SELL
$57.69 - $67.84 $51.3 Million - $60.3 Million
-888,453 Reduced 6.03%
13,845,095 $982 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $122 Million - $144 Million
2,406,836 Added 19.53%
14,733,548 $894 Million
Q1 2018

May 11, 2018

BUY
$50.96 - $59.23 $32 Million - $37.2 Million
628,128 Added 5.37%
12,326,712 $671 Million
Q4 2017

Feb 15, 2018

BUY
$51.62 - $61.64 $30.8 Million - $36.8 Million
597,089 Added 5.38%
11,698,584 $658 Million
Q3 2017

Nov 08, 2017

BUY
$58.67 - $63.13 $651 Million - $701 Million
11,101,495
11,101,495 $711 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.